search
Back to results

Tertiary Prevention in Type II Diabetes Mellitus in Canary Islands Study (INDICA)

Primary Purpose

Type 2 Diabetes Mellitus

Status
Completed
Phase
Not Applicable
Locations
Spain
Study Type
Interventional
Intervention
Intervention to patients
Intervention to professionals
Usual care
Sponsored by
Servicio Canario de Salud
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional prevention trial for Type 2 Diabetes Mellitus focused on measuring diabetes, self-management, lifestyle, diet, physical exercise, computer-assisted decision support systems

Eligibility Criteria

18 Years - 65 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

Patients:

  • T2DM diagnosis
  • aged between 18 and 65

Health professionals:

  • primary health care teams (PHCT) comprising a primary care physician and a nurse practitioner associated to a patient will be selected
  • must have a permanent position or a stable substitute position

Exclusion Criteria:

  • peripheral vascular disease
  • diabetic nephropathy and/or chronic kidney disease
  • cognitive impairment, dementia
  • major depression
  • insufficient level of Spanish
  • to be pregnant or planning to become pregnant in the next 6 months
  • cancer last 5 years
  • ischemic disease or heart failure
  • proliferative diabetic retinopathy

Sites / Locations

  • Servicio de Evaluación del Servicio Canario de la Salud

Arms of the Study

Arm 1

Arm 2

Arm 3

Arm 4

Arm Type

Experimental

Experimental

Experimental

Other

Arm Label

Intervention to Patients

Intervention to healthcare Professionals

Mixed Intervention

Control

Arm Description

Only patients receive intervention

Primary care physicians and nurses practitioners receive the intervention. Their associated patients do not receive direct intervention although indirect intervention through professionals

Patients and healthcare professionals (primary care physicians and nurses practitioners) associated with these patients receive intervention

Patients receive usual care

Outcomes

Primary Outcome Measures

Change in Glycosylated hemoglobin (HbA1c)
Change in Glycosylated hemoglobin from baseline to 12 months

Secondary Outcome Measures

Change in Glycosylated hemoglobin (HbA1c)
Change in Weight
Change in Waist circumference
Change in Body Mass Index (BMI)
Change in Basal glucose
Change in Total cholesterol level
Change in HDL level
Change in LDL level
Change in Triglycerides
Change in EQ-5D index
EQ-5D is a generic questionnaire for health related quality of life (HRQL) assessment
Change in ADDQoL score
ADDQoL is a specific questionnaire for health related quality of life (HRQL) assessment
Medication administration
Initiation of new drugs or dosage adjustment: insulin, antidiabetics, hypolipidemics, antihypertensives, etc.
Change in tabacco consumption
Acceptability of interventions and satisfaction (INDICA-SATP)
Change in Diabetes Knowledge
Change in Mediterranean Diet Adherence Screener (MEDAS) score
Change in International Physical Activity Questionnarie (IPAQ) score
Change in Stait-Trait Anxiety Inventory (STAI) score
Change in Beck Depression Inventory - II (BDI-II) score
Change in Diabetes Distress Scale (DDS2) score
Change in Diabetes Empowerment Scale - Short Form (DES-SF) score
Change in Morisky Compliance Scale

Full Information

First Posted
July 31, 2012
Last Updated
September 27, 2021
Sponsor
Servicio Canario de Salud
Collaborators
Instituto de Salud Carlos III, Asociación para la Diabetes de Tenerife, Asociación de Diabéticos de Gran Canaria
search

1. Study Identification

Unique Protocol Identification Number
NCT01657227
Brief Title
Tertiary Prevention in Type II Diabetes Mellitus in Canary Islands Study
Acronym
INDICA
Official Title
Effectiveness and Cost-effectiveness of Two Multi-component Interventions to Improve the Health Outcomes in People With Type 2 Diabetes Mellitus
Study Type
Interventional

2. Study Status

Record Verification Date
September 2021
Overall Recruitment Status
Completed
Study Start Date
January 2013 (undefined)
Primary Completion Date
October 20, 2016 (Actual)
Study Completion Date
October 20, 2016 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Servicio Canario de Salud
Collaborators
Instituto de Salud Carlos III, Asociación para la Diabetes de Tenerife, Asociación de Diabéticos de Gran Canaria

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
Objective: To improve health outcomes of patients with type 2 diabetes mellitus (T2DM) by influencing disease self-management through lifestyle modification and by helping primary care professionals to improve health care provided to patients. To assess the effectiveness and cost-effectiveness of two complex interventions (education and behavioural modification, independently and conjointly, for primary health care teams (PHCT) and patients and their relatives) to improve the health results in people with T2DM. Methodology: Design: Randomized clinical trial. Setting: Basic healthcare district in Canary Islands. Spain. Subjects: Patients with T2DM, 18-65 years old, without complications. Main measures: HbA1c, rate of patients with properly controlled T2DM. Sample: 2328 patients, 582 per arm. Intervention: G1: Interventions on the patients: Educational and habit modification group program. G2: Intervention on the PHCT: a) Educative intervention to improve the knowledge about the disease and their abilities; b) Computer-based clinical decision support system; c) Feedback of results. G3: Interventions on the patients and the PHCT. G4: Control group. Patients receive only the usual care.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Type 2 Diabetes Mellitus
Keywords
diabetes, self-management, lifestyle, diet, physical exercise, computer-assisted decision support systems

7. Study Design

Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
Outcomes Assessor
Masking Description
Participating FCUs were not told about their intervention assignment (groups 1-4) until the last patient agreed to participate at every FCU. To warrant patient participation and cooperation, interventions could neither be blinded to patients nor to healthcare professionals. Data analysis is blinded to the intervention assignment.
Allocation
Randomized
Enrollment
2334 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Intervention to Patients
Arm Type
Experimental
Arm Description
Only patients receive intervention
Arm Title
Intervention to healthcare Professionals
Arm Type
Experimental
Arm Description
Primary care physicians and nurses practitioners receive the intervention. Their associated patients do not receive direct intervention although indirect intervention through professionals
Arm Title
Mixed Intervention
Arm Type
Experimental
Arm Description
Patients and healthcare professionals (primary care physicians and nurses practitioners) associated with these patients receive intervention
Arm Title
Control
Arm Type
Other
Arm Description
Patients receive usual care
Intervention Type
Behavioral
Intervention Name(s)
Intervention to patients
Intervention Description
Multifaceted intervention consisting of: Program of education and behavior modification: group sessions conducted by health educators for the patient and a relative (who usually do the food shopping or prepare meals) every 3 months over 2 years (total:8 sessions). Main contents: diabetes, hygiene/nutrition and physical exercise. Monitoring of patient conditions by Informational Communication Technologies (ICT): patient will complete at home a web-based short questionnaire once a week and an expanded version once a month. Short text messaging to patient's mobile based on information obtained from self-reported questionnaires. 3 types of messages: 1) Reminders for completing web-based questionnaires, the attendance at group sessions and the follow-up appointments, 2) General advice on good habits, 3) Custom messages to reinforce behavior change.
Intervention Type
Behavioral
Intervention Name(s)
Intervention to professionals
Intervention Description
Multifaceted intervention consisting of: Educational intervention: Two theoretical and practical sessions to update knowledge on T2DM management and provide professionals with techniques to enhance the patient-centered clinical relationship model and the shared decision making model with the ultimate goal of improving patient adherence to treatment and self-care. Computer-based clinical decision support system (CDSS): Implementation of an automated tool combining evidence-based knowledge with patient-specific information to assist clinicians in making clinical decisions in the management of T2DM patients. Feedback: periodic mailing of personalized feedback reports with data on health results of all T2DM patients who are cared by the professional.
Intervention Type
Other
Intervention Name(s)
Usual care
Intervention Description
Usual care for T2DM received in primary health care
Primary Outcome Measure Information:
Title
Change in Glycosylated hemoglobin (HbA1c)
Description
Change in Glycosylated hemoglobin from baseline to 12 months
Time Frame
Baseline and 12 months
Secondary Outcome Measure Information:
Title
Change in Glycosylated hemoglobin (HbA1c)
Time Frame
Baseline and 3, 6, 18 and 24 months
Title
Change in Weight
Time Frame
Baseline and 3, 6, 12, 18 and 24 months
Title
Change in Waist circumference
Time Frame
Baseline and 3, 6, 12, 18 and 24 months
Title
Change in Body Mass Index (BMI)
Time Frame
Baseline and 3, 6,12, 18 and 24m
Title
Change in Basal glucose
Time Frame
Baseline and 3, 6, 12, 18 and 24 months
Title
Change in Total cholesterol level
Time Frame
Baseline and 6, 12 and 24 months
Title
Change in HDL level
Time Frame
Baseline and 6, 12 and 24 months
Title
Change in LDL level
Time Frame
Baseline and 6, 12 and 24 months
Title
Change in Triglycerides
Time Frame
Baseline and 6, 12 and 24 months
Title
Change in EQ-5D index
Description
EQ-5D is a generic questionnaire for health related quality of life (HRQL) assessment
Time Frame
Baseline and 6, 12, 18 and 24 months
Title
Change in ADDQoL score
Description
ADDQoL is a specific questionnaire for health related quality of life (HRQL) assessment
Time Frame
Baseline and 6, 12, 18 and 24 months
Title
Medication administration
Description
Initiation of new drugs or dosage adjustment: insulin, antidiabetics, hypolipidemics, antihypertensives, etc.
Time Frame
Baseline and 6, 12, 18 and 24 months
Title
Change in tabacco consumption
Time Frame
Baseline and 3, 6, 12, 18 and 24 months
Title
Acceptability of interventions and satisfaction (INDICA-SATP)
Time Frame
24 months
Title
Change in Diabetes Knowledge
Time Frame
Baseline, 12 and 24 months
Title
Change in Mediterranean Diet Adherence Screener (MEDAS) score
Time Frame
Baseline and 6, 12, 18 and 24 months
Title
Change in International Physical Activity Questionnarie (IPAQ) score
Time Frame
Baseline and 6, 12, 18 and 24 months
Title
Change in Stait-Trait Anxiety Inventory (STAI) score
Time Frame
Baseline, 12 and 24 months
Title
Change in Beck Depression Inventory - II (BDI-II) score
Time Frame
Baseline, 12 and 24 months
Title
Change in Diabetes Distress Scale (DDS2) score
Time Frame
Baseline, 12 and 24 months
Title
Change in Diabetes Empowerment Scale - Short Form (DES-SF) score
Time Frame
Baseline, 12 and 24 months
Title
Change in Morisky Compliance Scale
Time Frame
Baseline and 6, 12, 18 and 24 months
Other Pre-specified Outcome Measures:
Title
Incidence of micro- and macrovascular complications
Description
Coronary events, peripheral vascular complications, cerebral vascular complications, diabetic retinopathy, diabetic nephropathy
Time Frame
Baseline, 12 and 24 months
Title
Quality measures of the T2DM care process
Description
Adherence to recommendations on physical exam, lab test and treatment
Time Frame
Baseline and 6, 12, 18 and 24 months
Title
Resource utilization and costs
Time Frame
Baseline and 3, 6, 12, 18 and 24 months

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
65 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Patients: T2DM diagnosis aged between 18 and 65 Health professionals: primary health care teams (PHCT) comprising a primary care physician and a nurse practitioner associated to a patient will be selected must have a permanent position or a stable substitute position Exclusion Criteria: peripheral vascular disease diabetic nephropathy and/or chronic kidney disease cognitive impairment, dementia major depression insufficient level of Spanish to be pregnant or planning to become pregnant in the next 6 months cancer last 5 years ischemic disease or heart failure proliferative diabetic retinopathy
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Pedro G Serrano-Aguilar, MD, PhD
Organizational Affiliation
Servicio de Evaluación del Servicio Canario de la Salud
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Pedro Serrano Aguilar, MD, PhD
Organizational Affiliation
Servicio de Evaluación del Servicio Canario de la Salud
Official's Role
Study Director
First Name & Middle Initial & Last Name & Degree
Pedro Serrano Aguilar, MD, PhD
Organizational Affiliation
Servicio de Evaluación del Servicio Canario de la Salud
Official's Role
Study Chair
Facility Information:
Facility Name
Servicio de Evaluación del Servicio Canario de la Salud
City
Santa Cruz de Tenerife
ZIP/Postal Code
38004
Country
Spain

12. IPD Sharing Statement

Plan to Share IPD
Undecided
Citations:
PubMed Identifier
35396305
Citation
Garcia-Perez L, Ramallo-Farina Y, Vallejo-Torres L, Rodriguez-Rodriguez L, Gonzalez-Pacheco H, Santos-Hernandez B, Garcia-Bello MA, Wagner AM, Carmona M, Serrano-Aguilar PG; INDICA team. Cost-effectiveness of multicomponent interventions in type 2 diabetes mellitus in a cluster randomised controlled trial: the INDICA study. BMJ Open. 2022 Apr 8;12(4):e058049. doi: 10.1136/bmjopen-2021-058049.
Results Reference
derived
PubMed Identifier
34911711
Citation
Ramallo-Farina Y, Rivero-Santana A, Garcia-Perez L, Garcia-Bello MA, Wagner AM, Gonzalez-Pacheco H, Rodriguez-Rodriguez L, Kaiser-Girardot S, Monzon-Monzon G, Guerra-Marrero C, Daranas-Aguilar C, Roldan-Ruano M, Carmona M, Serrano-Aguilar PG; INDICA Team. Patient-reported outcome measures for knowledge transfer and behaviour modification interventions in type 2 diabetes-the INDICA study: a multiarm cluster randomised controlled trial. BMJ Open. 2021 Dec 15;11(12):e050804. doi: 10.1136/bmjopen-2021-050804.
Results Reference
derived
PubMed Identifier
33136059
Citation
Ramallo-Farina Y, Garcia-Bello MA, Garcia-Perez L, Boronat M, Wagner AM, Rodriguez-Rodriguez L, de Pablos-Velasco P, Llorente Gomez de Segura I, Gonzalez-Pacheco H, Carmona Rodriguez M, Serrano-Aguilar P; INDICA Team. Effectiveness of Internet-Based Multicomponent Interventions for Patients and Health Care Professionals to Improve Clinical Outcomes in Type 2 Diabetes Evaluated Through the INDICA Study: Multiarm Cluster Randomized Controlled Trial. JMIR Mhealth Uhealth. 2020 Nov 2;8(11):e18922. doi: 10.2196/18922.
Results Reference
derived
PubMed Identifier
25880498
Citation
Ramallo-Farina Y, Garcia-Perez L, Castilla-Rodriguez I, Perestelo-Perez L, Wagner AM, de Pablos-Velasco P, Dominguez AC, Cortes MB, Vallejo-Torres L, Ramirez ME, Martin PP, Garcia-Puente I, Salinero-Fort MA, Serrano-Aguilar PG; INDICA team. Effectiveness and cost-effectiveness of knowledge transfer and behavior modification interventions in type 2 diabetes mellitus patients--the INDICA study: a cluster randomized controlled trial. Implement Sci. 2015 Apr 9;10:47. doi: 10.1186/s13012-015-0233-1.
Results Reference
derived

Learn more about this trial

Tertiary Prevention in Type II Diabetes Mellitus in Canary Islands Study

We'll reach out to this number within 24 hrs